Cong Li
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
RCLARITY: A Prospective Phase II Study of Rituximab Combined With Lenalidomide and Chidamide (RLC) for the Treatment of Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma.
Journal: American journal of hematology
Published: February 03, 2026
Impact of positive CD4 cells on event-free survival in follicular lymphoma patients.
Journal: Cancer medicine
Published: May 28, 2024
A phase II study of sintilimab, anlotinib, and pegaspargase sandwiched with radiotherapy as first-line therapy in patients with newly diagnosed, stage I-II extranodal natural-killer/T-cell lymphoma.
Journal: American journal of hematology
Published: November 30, 2022
The Prognostic Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients.
Journal: Frontiers in oncology
Published: September 08, 2021
Bruton's tyrosine kinase inhibitors in primary central nervous system lymphoma-evaluation of anti-tumor efficacy and brain distribution.
Journal: Translational cancer research
Published: January 11, 2021
Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients.
Journal: Translational cancer research
Published: February 12, 2020
Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy.
Journal: BMC cancer
Published: October 20, 2019
Prognostic value of immunohistochemical factors in esophageal small cell carcinoma (ESCC): analysis of clinicopathologic features of 73 patients.
Journal: Journal of thoracic disease
Published: September 04, 2018
Last Updated: 09/26/2026